Highlights from the gynecologic oncology track at the 2017 Annual Meeting of the American Society of Clinical Oncology

被引：4
作者：
Wolford, Juliet E. [1 ]
Tewari, Krishnansu S. [1 ]
机构：
[1] Univ Calif Irvine, Div Gynecol Oncol, Irvine Med Ctr, Orange, CA 92668 USA
来源：
JOURNAL OF GYNECOLOGIC ONCOLOGY | 2017年 / 28卷 / 05期
关键词：
MAINTENANCE THERAPY; CANCER;
D O I：
10.3802/jgo.2017.28.e74
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：12
相关论文
共 24 条
[1]   Final results of the international randomized PORTEC-3 trial of adjuvant chemotherapy and radiation therapy (RT) versus RT alone for women with high-risk endometrial cancer [J].
de Boer, Stephanie M. ;
Powell, Melanie E. ;
Mileshkin, Linda R. ;
Katsaros, Dionyssios ;
Bessette, Paul ;
Haie-Meder, Christine ;
Ottevanger, Petronella B. ;
Ledermann, Jonathan A. ;
Khaw, Pearly ;
Colombo, Alessandro ;
Fyles, Anthony W. ;
Baron, Marie-Helene ;
Kitchener, Henry C. ;
Nijman, Hans ;
Kruitwagen, Roy F. P. M. ;
Jurgenliemk-Schulz, Ina M. ;
Nout, Remi A. ;
Smit, Vincent T. H. B. M. ;
Putter, Hein ;
Creutzberg, Carien L. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[2]   The successful phase 3 niraparib ENGOTOVl 6/NOVA trial included a substantial number of patients with platinum resistant ovarian cancer (OC). [J].
Del Campo, Jose Maria ;
Mirza, Mansoor Raza ;
Berek, Jonathan S. ;
Provencher, Diane M. ;
Emons, Guenter ;
Fabbro, Michel ;
Lord, Rosemary ;
Colombo, Nicoletta ;
Petru, Edgar ;
Wenham, Robert Michael ;
Herrstedt, Jorn ;
Gilbert, Lucy ;
Heubner, Martin Leonhard ;
Martin, Antonio Gonzalez ;
Follana, Philippe ;
Benigno, Benedict B. ;
Dorum, Anne ;
Rimel, B. J. ;
Hazard, Sebastien ;
Matulonis, Ursula A. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[3]   Phase II study of cabozantinib (cabo) in patients (pts) with recurrent/metastatic endometrial cancer (EC): A study of the Princess Margaret, Chicago, and California phase II consortia. [J].
Dhani, Neesha C. ;
Hirte, Hal W. ;
Burnier, Julia V. ;
Jain, Angela ;
Butler, Marcus . ;
Lheureux, Stephanie ;
Hurteau, Jean ;
Welch, Stephen ;
Matsuo, Koji ;
Method, Michael ;
Jimenez, Waldo ;
Johnston, Carolyn ;
Stringer, Erica ;
Cristea, Mihaela C. ;
Mehta, Anjali ;
Quintos, Judy ;
Tan, Susie ;
Wang, Lisa ;
Wright, John Joseph ;
Oza, Amit M. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[4]   Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III/ENGOT ov20 [J].
Du Bois, Andreas ;
Vergote, Ignace ;
Ferron, Gwenael ;
Reuss, Alexander ;
Meier, Werner ;
Greggi, Stefano ;
Jensen, Pernille Tina ;
Selle, Frededric ;
Guyon, Frederic ;
Pomel, Christophe ;
Lecuru, Fabrice ;
Zang, Rongyu ;
Avall-Lundqvist, Elisabeth ;
Kim, Jae Weon ;
Ponce, Jordi ;
Raspagliesi, Francesco ;
Ghaem-Maghami, Sadaf ;
Reinthaller, Alexander ;
Harter, Philipp ;
Sehouli, Jalid .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[5]   Health-related quality of life (HRQOL) and patient-centered outcomes with maintenance olaparib compared with placebo following chemotherapy in patients with germline (g) BRCA-mutated (m) platinum-sensitive relapsed serous ovarian cancer (PSR SOC): SOLO2 phase III trial [J].
Friedlander, Michael ;
Gebski, Val ;
Gibbs, Emma ;
Bloomfield, Ralph ;
Hilpert, Felix ;
Wenzel, Lari B. ;
Joly, Florence ;
Eek, Daniel ;
Rodrigues, Manuel ;
Clamp, Andrew R. ;
Penson, Richard T. ;
Provencher, Diane M. ;
Korach, Jacob ;
Huzarski, Tomasz ;
Vidal, Laura ;
Salutari, Vanda ;
Scott, Clare L. ;
Nicoletto, Maria Ornella ;
Tamura, Kenji ;
Pujade-Lauraine, Eric .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[6]   Impact of atezolizumab (atezo) treatment beyond disease progression (TBP) in advanced NSCLC: Results from the randomized phase III OAK study. [J].
Gandara, David R. ;
Von Pawel, Joachim ;
Sullivan, Richard N. ;
Helland, Aslaug ;
Han, Ji-Youn ;
Aix, Santiago Ponce ;
Rittmeyer, Achim ;
Barlesi, Fabrice ;
Kubo, Toshio ;
Park, Keunchil ;
Goldschmidt, Jerome H. ;
Gandhi, Mayank ;
Yun, Cindy ;
Yu, Wei ;
Matheny, Christina ;
He, Pei ;
Sandler, Alan ;
Ballinger, Marcus ;
Fehrenbacher, Louis .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[7]   Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum [J].
Gershenson, David M. ;
Bodurka, Diane C. ;
Coleman, Robert L. ;
Lu, Karen H. ;
Malpica, Anais ;
Sun, Charlotte C. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (10) :1103-+
[8]   Clinically significant long-term maintenance treatment with olaparib in patients (pts) with platinum-sensitive relapsed serous ovarian cancer (PSR SOC). [J].
Gourley, Charlie ;
Friedlander, Michael ;
Matulonis, Ursula A. ;
Shirinkin, Vadim ;
Selle, Frederic ;
Scott, Clare L. ;
Safra, Tamar ;
Fielding, Anitra ;
Rowe, Philip ;
Ledermann, Jonathan A. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[9]   LION: Lymphadenectomy in ovarian neoplasms-A prospective randomized AGO study group led gynecologic cancer intergroup trial [J].
Harter, Philipp ;
Sehouli, Jalid ;
Lorusso, Domenica ;
Reuss, Alexander ;
Vergote, Ignace ;
Marth, Christian ;
Kim, Jae Weon ;
Raspagliesi, Francesco ;
Lampe, Boern ;
Landoni, Fabio ;
Meier, Werner ;
Cibula, David ;
Mustea, Alexander ;
Mahner, Sven ;
Runnebaum, Ingo B. ;
Schmalfeldt, Barbara ;
Burges, Alexander ;
Kimmig, Rainer ;
Wagner, Uwe A. G. ;
Du Bois, Andreas .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[10]  
Hayes DF., 2016, MAKING DIFFERENCE CA
123